Log In
Print
BCIQ
Print
Print this Print this
 

ganitumab (AMG 479)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb antagonist of insulin-like growth factor-1 (IGF-1) receptor (IGF1R)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionInsulin-like growth factor-1 (IGF-1) receptor antagonist
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today